Full data view for gene PMS2


PMS2 variants classified by the InSiGHT consortium: criteria used for classification are available here. We encourage submission of relevant unpublished information to assist in the classification of variants via LOVD or this template which can be emailed to the curator.
Information The variants shown are described using the NM_000535.6 transcript reference sequence.

8 entries on 1 page. Showing entries 1 - 8.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+?/. - c.319C>T r.(?) p.(Arg107Trp) Unknown - likely pathogenic g.6043355G>A g.6003724G>A - - PMS2_000299 VKGL data sharing initiative Nederland - - - CLASSIFICATION record - - - - - - - - - - - - - - - - - - - - - - -
+?/. 4 c.319C>T r.[319c>u, ?] p.(Arg107Trp) Unknown - likely pathogenic g.6043355G>A g.6003724G>A - - PMS2_000299 Patient RNA not available. Minigene: 3 transcripts: full lengthkip first 53 nt of exon 4, out of frame skip exon 4 PubMed: van der Klift 2015 - - Unknown - - - - - DNA, RNA RT-PCR, SEQ - - CRC - - - F - Netherlands - - - - - 1 Carli Tops
?/. - c.319C>T r.(?) p.(Arg107Trp) Unknown - VUS g.6043355G>A g.6003724G>A - - PMS2_000299 - PubMed: ten Broeke 2015, PubMed: Suerink 2016, PubMed: van der Klift 2015, PubMed: van der Klift 2016, PubMed: Stelloo 2017 - - Germline/De novo (untested) - - - - - DNA SEQ-NG - Test performed in 2014. Testing coverage: ATM, BARD1, BLM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, EPCAM, FAM175A, FANCC, HOXB13, MLH1, MRE11A, MSH2, MSH6, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, STK11, TP53, XRCC2 cancer, ovarian - - - F - (United States) - - - - - 1 InSiGHT - John-Paul Plazzer
?/. - c.319C>T r.(?) p.(Arg107Trp) Unknown - VUS g.6043355G>A g.6003724G>A - - PMS2_000299 - PubMed: ten Broeke 2015, PubMed: Suerink 2016, PubMed: van der Klift 2015, PubMed: van der Klift 2016, PubMed: Stelloo 2017 - - Germline - - - - - DNA SEQ-NG - Year test performed: 2018. Testing coverage: APC, ATM, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, SCG5/GREM1, SMAD4, STK11, TP53, VHL cancer, kidney - - - M - (United States) - - - - - 2 InSiGHT - John-Paul Plazzer
?/. - c.319C>T r.(?) p.(Arg107Trp) Unknown - VUS g.6043355G>A g.6003724G>A - - PMS2_000299 - PubMed: ten Broeke 2015, PubMed: Suerink 2016, PubMed: van der Klift 2015, PubMed: van der Klift 2016, PubMed: Stelloo 2017 - - Germline - - - - - DNA SEQ - Testing was stopped when variant found. Healthy/Control - - - M - (United States) - - - - - 2 InSiGHT - John-Paul Plazzer
?/. - c.319C>T r.(?) p.(Arg107Trp) Paternal (confirmed) - VUS g.6043355G>A g.6003724G>A - - PMS2_000299 - PubMed: ten Broeke 2015, PubMed: Suerink 2016, PubMed: van der Klift 2015, PubMed: van der Klift 2016, PubMed: Stelloo 2017 - - Germline - - - - - DNA ? - - cancer, colon - - - M - (United States) - - - - - 1 InSiGHT - John-Paul Plazzer
?/. - c.319C>T r.(?) p.(Arg107Trp) Unknown - VUS g.6043355G>A g.6003724G>A - - PMS2_000299 - PubMed: ten Broeke 2015, PubMed: Suerink 2016, PubMed: van der Klift 2015, PubMed: van der Klift 2016, PubMed: Stelloo 2017 - - Germline - - - - - DNA ? - - cancer, colon - - - F - (United States) - - - - - 1 InSiGHT - John-Paul Plazzer
?/. - c.319C>T r.(?) p.(Arg107Trp) Parent #1 - NA g.6043355G>A - chr7_6043355_G_A - PMS2_000299 not in 53461 controls; the study was not designed to clinically classify individual variants but performed burden-type association analyses, grouping certain variant types PubMed: Dorling 2021, Journal: Dorling 2021 - - Germline - 1/60466 cases - - - DNA SEQ-NG - 34-gene panel cancer, breast - PubMed: Dorling 2021, Journal: Dorling 2021 analysis 60466 cases (BRIDGES) - - - - - - bcac.ccge.medschl.cam.ac.uk/contact - 1 BRIDGES consortium
Legend   How to query  


Screenscraping/webscraping (interacting with LOVD using scripts to download data) is strictly prohibited.
Use our APIs to retrieve data.